Document is current
Any future updates will be listed below
-
Authors
Misery, Laurent
Dutray, Sabine
Chastaing, Myriam
Schollhammer, Martine
Consoli, Sylvie G.
Consoli, Silla M.
-
License Information
Text and Data Mining valid from 2018-03-01
-
More Information
Article History
Received: 27 July 2017
Revised: 6 October 2017
Accepted: 1 November 2017
First Online: 1 March 2018
Conflict of interest
: L.M. reports competing interests with Abbvie, Amgen, Astellas, BASF, Beiersdorf, Bioderma, Celege, Clarins, Expanscience, Galderma, Johnson&Johnson, Novartis, Pfizer, Pierre Fabre, Sanofi, and Uriage. S.M.C.—conferences or brochures: Sanofi, Gilead, Bouchara-Recordati, Merck-Sharpe & Dohme, and NovoNordisk; scientific board of a clinical trial: Gilead; travel funds: Sanofi. S.D., M.C., M.S., and S.G.C. declare that they have no conflict of interest.
